|Slideshows|September 10, 2019

High Rates of Autistic Symptoms Found in Patients With Eating Disorders

What is the link between restrictive anorexia, anorexia nervosa, and binge eating disorder and ASD? This study sheds some light.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD

ByLeah Kuntz,Jennifer L. Payne, MD

October 15th 2025

Acetaminophen Use During Pregnancy Does Not Increase ADHD or Autism Risk: A Conversation With Sarah Oreck, MD, MS

ByLeah Kuntz,Sarah Oreck, MD, MS

October 2nd 2025

Stay Updated on AI Chatbots With a New Series From Allen Frances, MD

ByAllen Frances, MD

September 11th 2025

Sleep-Related Eating Disorder: A Distressing But Treatable Complex Parasomnia

ByCarlos H. Schenck, MD,Ranji Varghese, MD

August 13th 2025

The Relationship Between Sex Hormones and Eating Disorders Like Bulimia Nervosa and Binge Eating

ByTom Hildebrandt, PsyD

August 1st 2025

Latest CME

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Register now!

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

High Rates of Autistic Symptoms Found in Patients With Eating Disorders

Newsletter

Related Content

Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD

Acetaminophen Use During Pregnancy Does Not Increase ADHD or Autism Risk: A Conversation With Sarah Oreck, MD, MS

Stay Updated on AI Chatbots With a New Series From Allen Frances, MD

Sleep-Related Eating Disorder: A Distressing But Treatable Complex Parasomnia

The Relationship Between Sex Hormones and Eating Disorders Like Bulimia Nervosa and Binge Eating

Latest CME

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Lamotrigine: An Update on Its Role in Bipolar Disorder

FDA Clears Deep Transcranial Magnetic Stimulation for Adolescents With MDD

In Memoriam: 2 Terrible Ironies of Being a Psychiatrist

Everything You Need to Know About the Approval of Lumateperone for Major Depressive Disorder

Post-Hoc Analysis of Predictive Factors for Response to Adjunctive Cobenfy